Morning Cortisol Levels and Cognitive Abilities in People with Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2010 Jan 26

PMID 20097784

Citations 30

Authors

Rebecca M Reynolds

Mark W J Strachan

Javier Labad

Amanda J Lee

Brian M Frier

F Gerald Fowkes

Rory Mitchell

Jonathan R Seckl

Ian J Deary

Brian R Walker

Jackie F Price

Affiliations

Soon will be listed here.

Abstract

Objective: People with type 2 diabetes are at increased risk of cognitive impairment but the mechanism is uncertain. Elevated glucocorticoid levels in rodents and humans are associated with cognitive impairment. We aimed to determine whether fasting cortisol levels are associated with cognitive ability and estimated lifetime cognitive change in an elderly population with type 2 diabetes.

Research Design And Methods: This was a cross-sectional study of 1,066 men and women aged 60-75 years with type 2 diabetes, living in Lothian, Scotland (the Edinburgh Type 2 Diabetes Study). Cognitive abilities in memory, nonverbal reasoning, information processing speed, executive function, and mental flexibility were tested, and a general cognitive ability factor, g, was derived. Prior intelligence was estimated from vocabulary testing, and adjustment for scores on this test was used to estimate lifetime cognitive change. Relationships between fasting morning plasma cortisol levels and cognitive ability and estimated cognitive change were tested. Models were adjusted for potential confounding and/or mediating variables including metabolic and cardiovascular variables.

Results: In age-adjusted analyses, higher fasting cortisol levels were not associated with current g or with performance in individual cognitive domains. However, higher fasting cortisol levels were associated with greater estimated cognitive decline in g and in tests of working memory and processing speed, independent of mood, education, metabolic variables, and cardiovascular disease (P < 0.05).

Conclusions: High morning cortisol levels in elderly people with type 2 diabetes are associated with estimated age-related cognitive change. Strategies targeted at lowering cortisol action may be useful in ameliorating cognitive decline in individuals with type 2 diabetes.

Citing Articles

Review of the direct and indirect effects of hyperglycemia on the HPA axis in T2DM and the co-occurrence of depression.

Mosili P, Mkhize B, Sibiya N, Ngubane P, Khathi A BMJ Open Diabetes Res Care. 2024; 12(1).

PMID: 38413177 PMC: 10900365. DOI: 10.1136/bmjdrc-2022-003218.

Adrenocortical pheochromocytoma diagnosed during pregnancy: a case report.

Qiang X, Li Y, Bai Q, Huang J, Ma X, Wang W BMC Pregnancy Childbirth. 2023; 23(1):527.

PMID: 37464302 PMC: 10354947. DOI: 10.1186/s12884-023-05844-7.

Risk of dementia associated with body mass index, changes in body weight and waist circumference in older people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.

Chen B, Sluiman A, Khalid W, Strachan M, Price J Diabet Med. 2023; 40(5):e15063.

PMID: 36756713 PMC: 10947035. DOI: 10.1111/dme.15063.

Longitudinal associations between sleep duration and cognitive impairment in Chinese elderly.

Chen W, Wang X Front Aging Neurosci. 2022; 14:1037650.

PMID: 36466606 PMC: 9714471. DOI: 10.3389/fnagi.2022.1037650.

Diabetes and associated cognitive disorders: Role of the Hypothalamic-Pituitary Adrenal axis.

Marissal-Arvy N, Moisan M Metabol Open. 2022; 15:100202.

PMID: 35958117 PMC: 9357829. DOI: 10.1016/j.metop.2022.100202.

References

Liu H, Bravata D, Cabaccan J, Raff H, Ryzen E . Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxf). 2005; 63(6):642-9. DOI: 10.1111/j.1365-2265.2005.02395.x. View

Reynolds R, Walker B, Syddall H, Whorwood C, Wood P, Phillips D . Elevated plasma cortisol in glucose-intolerant men: differences in responses to glucose and habituation to venepuncture. J Clin Endocrinol Metab. 2001; 86(3):1149-53. DOI: 10.1210/jcem.86.3.7300. View

Gold S, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H . Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia. 2007; 50(4):711-9. DOI: 10.1007/s00125-007-0602-7. View

Bruehl H, Wolf O, Sweat V, Tirsi A, Richardson S, Convit A . Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009; 1280:186-94. PMC: 2749480. DOI: 10.1016/j.brainres.2009.05.032. View

Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S . Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care. 2006; 30(1):83-8. DOI: 10.2337/dc06-1267. View

Cameron O, Thomas B, Tiongco D, Hariharan M, Greden J . Hypercortisolism in diabetes mellitus. Diabetes Care. 1987; 10(5):662-4. DOI: 10.2337/diacare.10.5.662. View

Vallee M, Maccari S, Dellu F, Simon H, Le Moal M, Mayo W . Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat. Eur J Neurosci. 1999; 11(8):2906-16. DOI: 10.1046/j.1460-9568.1999.00705.x. View

Hudson J, Hudson M, Rothschild A, Vignati L, Schatzberg A, MELBY J . Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch Gen Psychiatry. 1984; 41(11):1086-9. DOI: 10.1001/archpsyc.1983.01790220076012. View

Strachan M, Reynolds R, Frier B, Mitchell R, Price J . The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies. Diabetes Obes Metab. 2009; 11(5):407-14. DOI: 10.1111/j.1463-1326.2008.00963.x. View

10.

Price J, Reynolds R, Mitchell R, Williamson R, Fowkes F, Deary I . The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord. 2008; 8:18. PMC: 2621220. DOI: 10.1186/1472-6823-8-18. View

11.

Cameron O, Kronfol Z, Greden J, Carroll B . Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry. 1984; 41(11):1090-5. DOI: 10.1001/archpsyc.1983.01790220080013. View

12.

Andrews R, Herlihy O, Livingstone D, Andrew R, Walker B . Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab. 2002; 87(12):5587-93. DOI: 10.1210/jc.2002-020048. View

13.

Yau J, Noble J, Hibberd C, Rowe W, Meaney M, Morris R . Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J Neurosci. 2002; 22(4):1436-42. PMC: 6757572. View

14.

Bruehl H, Rueger M, Dziobek I, Sweat V, Tirsi A, Javier E . Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab. 2007; 92(7):2439-45. DOI: 10.1210/jc.2006-2540. View

15.

Reynolds R, Walker B, Syddall H, Andrew R, Wood P, Whorwood C . Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab. 2001; 86(1):245-50. DOI: 10.1210/jcem.86.1.7145. View

16.

Sandeep T, Yau J, MacLullich A, Noble J, Deary I, Walker B . 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci U S A. 2004; 101(17):6734-9. PMC: 404114. DOI: 10.1073/pnas.0306996101. View

17.

MacLullich A, Deary I, Starr J, Ferguson K, Wardlaw J, Seckl J . Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology. 2005; 30(5):505-15. DOI: 10.1016/j.psyneuen.2004.12.005. View

18.

Lee Z, Chan J, Yeung V, Chow C, Lau M, Ko G . Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care. 1999; 22(9):1450-7. DOI: 10.2337/diacare.22.9.1450. View

19.

Stranahan A, Arumugam T, Cutler R, Lee K, Egan J, Mattson M . Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci. 2008; 11(3):309-17. PMC: 2927988. DOI: 10.1038/nn2055. View

20.

Seckl J, Dickson K, Yates C, Fink G . Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 1991; 561(2):332-7. DOI: 10.1016/0006-8993(91)91612-5. View